Old Web
English
Sign In
Acemap
>
authorDetail
>
Joana Parreira
Joana Parreira
Hoffmann-La Roche
Internal medicine
Follicular lymphoma
Obinutuzumab
Medicine
short duration
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies.
2021
Thomas D. Rodgers
Carla Casulo
Frédéric Boissard
Aino Launonen
Joana Parreira
Guillaume Cartron
Show All
Source
Cite
Save
Citations (0)
OBINUTUZUMAB CAN BE ADMINISTERED AS A 90‐MINUTE SHORT‐DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: GAZELLE END OF INDUCTION ANALYSIS
2021
Hematological Oncology
K Hübel
Thomas A. Buchholz
Koji Izutsu
Takayuki Ishikawa
Laura Fogliatto
E. Vorozheikina
D. Klingbiel
S. Pokala
Monique S Tomiczek
Joana Parreira
Miguel Canales
Show All
Source
Cite
Save
Citations (0)
Obinutuzumab Short Duration Infusion Is Preferred By Healthcare Providers and Has Minimal Impact on Patient-Reported Symptoms Among Patients with Untreated, Advanced Follicular Lymphoma
2021
Blood
Peter Trask
Jaisson Bortolini
Shinya Rai
Antonio Salar
Miguel Canales
Dirk Klingbiel
Joana Parreira
Maud Deraet
Ekaterina Vorozheikina
Kai Hübel
Thomas A. Buchholz
Show All
Source
Cite
Save
Citations (0)
Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study.
2021
Journal of Clinical Oncology
Miguel Ángel Canales Albendea
Thomas A. Buchholz
Koji Izutsu
Takayuki Ishikawa
Laura Fogliatto
Ekaterina Vorozheikina
D. Klingbiel
Sunny Pokala
Monique S Tomiczek
Joana Parreira
Kai Hübel
Show All
Source
Cite
Save
Citations (0)
1